| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HRMY | Common Stock | Options Exercise | $82,200 | +10,000 | $8.22* | 10,000 | 01 Nov 2021 | Direct | ||
| transaction | HRMY | Common Stock | Sale | $291,725 | -7,054 | -71% | $41.36 | 2,946 | 01 Nov 2021 | Direct | F1, F2 |
| transaction | HRMY | Common Stock | Sale | $125,015 | -2,946 | -100% | $42.44 | 0 | 01 Nov 2021 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HRMY | Stock Option | Options Exercise | $0 | -6,048 | -31% | $0.000000 | 13,429 | 01 Nov 2021 | Common Stock | 6,048 | $8.22 | Direct | F4, F5 |
| transaction | HRMY | Stock Option | Options Exercise | $0 | -3,952 | -17% | $0.000000 | 19,476 | 01 Nov 2021 | Common Stock | 3,952 | $8.22 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.03 to $42.02. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.03 to $43.00. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The stock option is currently vested with respect to 3,690 shares, and will vest with respect to the remainder of the shares on October 1, 2022. |
| F5 | Reflects 785 additional stock options which were erroneously reported as exercised on the Form 4 filed by the reporting person on September 3, 2021, but which were actually exercised from the tranche which expires on October 1, 2028. |
| F6 | The stock option is currently vested with respect to 0 shares, and will vest with respect to the remainder of the shares in four equal annual installments beginning on March 1, 2022. |